Clinical Trial Update: Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating neoadjuvant immunotherapy plus chemotherapy, followed by concurrent chemoradiotherapy and consolidative immunotherapy, for locally ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Neoadjuvant Therapy, Concurrent Chemoradiotherapy | Phase 3 | Status: RECRUITING